Indications:

Shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses. Duration of immunity is at least 3 years.

EFFICACY & COMPARISONS

ONLY 3-year labeled HCP vaccine option for cats.

• Proven in a 3-year real-time challenge-of-immunity HCP study⁷³

NOBIVAC^® FELINE 3-HCP IS A SAFE CHOICE

• Less likely to produce local and systemic reactions⁷²
• Extended duration of immunity (DOI) to minimize the number of injections
• Nobivac^® Feline 3-HCP is the only USDA-approved, 3-year vaccine for rhinotracheitis, calicivirus, and panleukopenia
  • 3-year DOI proven in challenge studies⁷³
• American Association of Feline Practitioners (AAFP) has recommended 3-year vaccination intervals for core antigens such as HCP⁶⁸

ADMINISTRATION AND DOSAGE

• Subcutaneous injection
• Initial 1 mL dose administered at 8 weeks or older
• Booster injection administered 3 to 4 weeks following the initial vaccination
• Cats 12 weeks of age or older should receive two 1 mL doses 3 to 4 weeks apart
• Revaccination with 1 dose is recommended every 3 years
• Available in a 25 x 1 mL dose presentation

DISEASE INFORMATION

• Feline Panleukopenia
• Feline Viral Upper Respiratory Tract Disease